REDD1 Deficiency Alleviates Autophagic Flux Impairment Via Inhibiting NLRP3 Inflammasome-Mediated Notch1 Signaling Pathway in Diabetic Kidney Disease

Zhifen Yang,Ming Wu,Nan Chen,Huandi Zhou,Chen Yuan,Zihui Zhou,Lin Mu,Jiajia Dong,Yawei Bian,Yonghong Shi
DOI: https://doi.org/10.2139/ssrn.4061018
2022-01-01
Abstract:Diabetic kidney disease (DKD) is the most-common cause of chronic renal failure and end-stage renal disease (ERSD) in diabetes mellitus. Autophagy impairment is implicated in the progression of DKD. REDD1 is a stress-regulated protein whose levels are increased in several neurodegenerative diseases. The effect of REDD1 on autophagy has been investigated; however, it has not been investigated whether and how REDD1 regulates autophagy in DKD. Here, we identified that REDD1 was up-regulated both in the renal samples of patients with diabetic nephropathy and diabetic mice from GEO database. Next, defective autophagy was observed in kidneys of db/db mice and in high glucose (HG) - treated HK-2 cells, which were restored by REDD1 deficiency. Consequently, we indicated that REDD1 was attributed to the activation of Nucleotide leukin-rich polypeptide 3 (NLRP3) inflammasome and Notch1 signaling pathway both in db/db mice and HG-treated HK-2 cells. Then, further assessment showed that NLRP3 inhibition protected against defective autophagy, and block Notch1 signaling pathway under diabetic conditions using streptozotocin (STZ)-induced diabetic NLRP3 knockout (NKO) mice and MCC950-treated db/db mice. Meanwhile, we detected that both NLRP3 and Notch1 deficiency promoted autophagy. Importantly, IL-1β aggravated the above-mentioned defective autophagy, and promoted Notch1 expression in HK-2 cells under HG conditions. Taken together, the results of our study demonstrated that REDD1 governed autophagy with the participation of NLRP3-mediated Notch1 signaling. Regulation of REDD1 may be a potential therapeutic approach for DKD.
What problem does this paper attempt to address?